Detalhe da pesquisa
1.
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Proc Natl Acad Sci U S A
; 118(15)2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876771
2.
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Cancer
; 128(6): 1206-1218, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875107
3.
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Br J Cancer
; 126(12): 1695-1703, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149854
4.
Declining use of inguinofemoral lymphadenectomy in the treatment of clinically negative, pathologic node positive vulvar cancer.
Gynecol Oncol
; 166(1): 61-68, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550710
5.
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
Gynecol Oncol
; 166(2): 351-357, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641325
6.
Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor.
Gynecol Oncol
; 166(1): 117-125, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35599167
7.
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
Proc Natl Acad Sci U S A
; 116(2): 619-624, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30584090
8.
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
Proc Natl Acad Sci U S A
; 116(45): 22730-22736, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31624127
9.
Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu.
Gynecol Oncol
; 163(1): 93-99, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372971
10.
DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
Gynecol Oncol
; 163(2): 334-341, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452746
11.
Robotic Low Anterior Resection and Partial Bladder Resection for Management of Locoregional Endometrial Cancer Recurrence.
J Minim Invasive Gynecol
; 28(2): 176-177, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32544562
12.
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Gynecol Oncol
; 158(3): 769-775, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600791
13.
In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.
Gynecol Oncol
; 156(2): 430-438, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839338
14.
Robotic Tumor Debulking off External Iliac Vessels for the Management of Recurrent Ovarian Cancer.
J Minim Invasive Gynecol
; 27(5): 1021-1022, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610315
15.
Robotic Colostomy Takedown in a Patient with Extensive Ventral Hernias and Adhesive Disease.
J Minim Invasive Gynecol
; 27(6): 1256-1257, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838277
16.
Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Br J Cancer
; 130(6): 1073, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438590
17.
Robotic type II B posterior exenteration for recurrent vaginal cancer.
Gynecol Oncol
; 155(2): 384-385, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345607
18.
PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.
Gynecol Oncol
; 155(1): 144-150, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434613
19.
PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.
Gynecol Oncol
; 153(1): 158-164, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630630
20.
Challenges of Robotic Gynecologic Surgery in Morbidly Obese Patients and How to Optimize Success.
Curr Pain Headache Rep
; 23(7): 51, 2019 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263977